Last reviewed · How we verify

NCT04960098

Patient-reported Outcome Measures in Patient Underwent Total Hip and Knee Arthroplasty

Recruiting now Last updated 19 July 2021
What this trial tests

trial testing arthroplasty in Hip Osteoarthritis in 5,816 participants. Currently enrolling.

Timeline
12 January 2016
Primary endpoint
31 December 2050
31 December 2050

Quick facts

Lead sponsorI.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment5,816
Start date12 January 2016
Primary completion31 December 2050
Estimated completion31 December 2050
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio — full company profile →

Who can join

18 and older, any sex, with Hip Osteoarthritis or Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Registry of Galeazzi Orthopedic Institute: provides for the regular and systematic collection of all data (clinical and some PROMs) obtained from patients undergoing hip and knee arthroplasty to which questionnaires are proposed investigating the specific functional sphere of the joints undergoing surgery (Knee injuryOsteoarthritisOutcomeScore (KOOS-PS) and Hip injuryOsteoarthritisOutcomeScore (HOOS-PS) but also the sphere of general health (ShortForm health survey-12 (SF-12) and VisualAnalogueScale (VAS)) , in addition, of course, to the satisfaction rate.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of arthroplasty

Trials testing the same drug.

Other recruiting trials for Hip Osteoarthritis

Currently open trials in the same condition.

Other I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04960098.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing